Trials / Completed
CompletedNCT02570035
Specified Drug Use-results Survey of Betanis Tablets for Patients With Coexisting Cardiovascular Disease
Protocol for Specified Drug Use-results Survey of Betanis Tablets (for Patients With Coexisting Cardiovascular Disease)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 316 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This purpose of this study is to investigate the effects of mirabegron on the cardiovascular system in patients with overactive bladder with current or a history of cardiovascular disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mirabegron | oral |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2015-03-01
- Completion
- 2015-03-01
- First posted
- 2015-10-07
- Last updated
- 2015-10-07
Locations
28 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT02570035. Inclusion in this directory is not an endorsement.